1069 related articles for article (PubMed ID: 24215461)
21. [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
Uchida K; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 Sep; 44(9):1007-12. PubMed ID: 1960850
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes.
Singh J; Zaman M; Gupta AK
Med Mycol; 2007 Nov; 45(7):595-602. PubMed ID: 17885958
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
[TBL] [Abstract][Full Text] [Related]
25. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
Ozkutuk A; Ergon C; Yulug N
Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of azole derivatives and griseofulvin against planktonic and biofilm growth of clinical isolates of dermatophytes.
Brilhante RSN; Correia EEM; Guedes GMM; de Oliveira JS; Castelo-Branco DSCM; Cordeiro RA; Pinheiro AQ; Chaves LJQ; Pereira Neto WA; Sidrim JJC; Rocha MFG
Mycoses; 2018 Jul; 61(7):449-454. PubMed ID: 29517824
[TBL] [Abstract][Full Text] [Related]
27. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
Santos DA; Hamdan JS
Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial effect of fluconazole, itraconazole, and terbinafine with different culture extracts of Candida parapsilosis and Trichophyton spp. against Trichophyton rubrum.
Lemes TH; Nascentes JAS; Regasini LO; Siqueira JPZ; Maschio-Lima T; Pattini VC; Ribeiro MD; de Almeida BG; de Almeida MTG
Int Microbiol; 2024 Jun; 27(3):899-905. PubMed ID: 37875749
[TBL] [Abstract][Full Text] [Related]
29. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method.
Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E
Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.
Bao YQ; Wan Z; Li RY
Mycopathologia; 2013 Feb; 175(1-2):141-5. PubMed ID: 22983900
[TBL] [Abstract][Full Text] [Related]
31. Antidermatophytic activity of allylamine derivatives.
Venugopal PV; Venugopal TV
Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.
Araújo CR; Miranda KC; Fernandes Ode F; Soares AJ; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2009; 51(1):9-12. PubMed ID: 19229384
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers.
Kermani F; Javidnia J; Hedayati MT; Abastabar M; Haghani I; Didehdar M; Fami Zaghrami M; Shokohi T
Mycoses; 2020 Dec; 63(12):1321-1330. PubMed ID: 32854165
[TBL] [Abstract][Full Text] [Related]
34. Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods.
Mota CR; Miranda KC; Lemos Jde A; Costa CR; Hasimoto e Souza LK; Passos XS; Meneses e Silva H; Silva Mdo R
Rev Soc Bras Med Trop; 2009; 42(3):250-4. PubMed ID: 19684970
[TBL] [Abstract][Full Text] [Related]
35. Common dermatophytes and in vitro anti-fungal susceptibility testing in patients attending the Dermatological Clinic at the Hospital for Tropical Medicine, Bangkok.
Muangkaew W; Wongsuk T; Luplertlop N
New Microbiol; 2017 Jul; 40(3):175-179. PubMed ID: 28513812
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.
Macura AB
Int J Dermatol; 1993 Jul; 32(7):533-6. PubMed ID: 8340195
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Barros MEDS; Santos DA; Hamdan JS
J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
39. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
40. A study of dermatophytes and their in-vitro antifungal sensitivity.
Sumana MN; Rajagopal V
Indian J Pathol Microbiol; 2002 Apr; 45(2):169-72. PubMed ID: 12696733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
